Skip to main content
Caplight Logo









Eluciderm, Inc.

Eluciderm, Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.eluciderm.com/

Last Round

VC Round

Jun 18, 2024

Total Funding Raised

$375,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Eluciderm, Inc. is a biotechnology company that develops topically administered small-molecule drugs intended to facilitate scarless wound healing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

wound healingbiotechnologysmall-molecule therapeuticsELU42Wnt signaling modulatorclinical-stage pharmadrug developmentdermatological recoverysurgical recoverybiotech startupwound carelife sciencesregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eluciderm, Inc. Comparables

Compare Eluciderm, Inc. with similar companies based on industry and business-model similarity.

Eluciderm, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PolarityBio, Inc.
81%
Healiva SA
79%
Omeza
79%

Eluciderm, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 18, 2024
VC RoundApr 22, 2022
SeedOct 4, 2021

Key People

Founding team and executive leadership

John Delgado

Co-Founder, Chief Medical Officer

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Presented a poster at the 2026 Symposium on Advanced Wound Care.

  • Apr 20, 2026

    Won second international wound healing award for product ELU42.

Eluciderm, Inc. Filings

Explore SEC and related filing metadata, where available.

Eluciderm, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eluciderm, Inc.'s valuation, stock price, and market status.

Is Eluciderm, Inc. a public or private company?

Eluciderm, Inc. is a private company.

What is the current stock price of Eluciderm, Inc.?

Eluciderm, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Eluciderm, Inc. worth (valuation)?

Valuation information for Eluciderm, Inc. is not publicly available.

Can I buy Eluciderm, Inc. stock?

Eluciderm, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eluciderm, Inc.'s last funding round?

Eluciderm, Inc.'s most recent funding round was VC Round on June 18, 2024.

Who are the main investors in Eluciderm, Inc.?

Investor information for Eluciderm, Inc. is not publicly disclosed.

Will Eluciderm, Inc. IPO soon?

No public IPO plans have been announced for Eluciderm, Inc..

How can I track Eluciderm, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eluciderm, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range2
Year Founded2018
Last FundingJun 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?